Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
MNPR
7 quarters
Position history for RA Capital Management, L.P.'s holdings in Monopar Therapeutics Inc.
Yes. RA Capital Management holds 667,207 shares of MNPR (Monopar Therapeutics), worth $61.8M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held MNPR since Q4 2024, across 7 quarterly 13F filings. MNPR is 0.5% of RA Capital Management's reported 13F portfolio.
Current Value
$61.8M
Current Shares
667,207
Total Value Change
+$50.5M
Total Shares Change
+156,000
Quarter-by-Quarter History